UDN Sites
CLINICAL SITES
- Bethesda, MD (NIH Undiagnosed Diseases Program)
- Boston, MA (UDN Clinical Site at Harvard Medical School) *no longer reviewing new applications effective April 8, 2022*
- Durham, NC (Duke University and Columbia University) *reopened to new applications effective September 23, 2022*
- Houston, TX (Baylor College of Medicine, Texas Children’s Hospital, and Baylor CHI St. Luke’s Medical Center)
- Los Angeles, CA (UCLA Undiagnosed Diseases Clinic) *no longer reviewing new applications effective February 7, 2022*
- Miami, FL (University of Miami School of Medicine)
- Nashville, TN (Vanderbilt Center for Undiagnosed Diseases) *reopened to new applications effective July 27, 2022*
- Philadelphia, PA (Children’s Hospital of Philadelphia and University of Pennsylvania) *reopened to new applications effective August 9, 2022*
- Salt Lake City, UT (University of Utah – Intermountain West) *no longer reviewing new applications effective April 8, 2022*
- Seattle, WA (Pacific Northwest Undiagnosed Diseases Clinical Site at University of Washington and Seattle Children’s Hospital)
- Stanford, CA (Center for Undiagnosed Diseases at Stanford) *no longer reviewing new applications effective March 1, 2022*
- St. Louis, MO (Washington University in St. Louis)
CENTRAL BIOREPOSITORY
- Nashville, TN (Vanderbilt University Medical Center)
COORDINATING CENTER
- Boston, MA (Harvard Medical School and University of Alabama at Birmingham)
METABOLOMICS CORE
- Rochester, MN (Mayo Clinic)
MODEL ORGANISM SCREENING CENTERS
- Houston, TX (Baylor College of Medicine and University of Oregon)
- St. Louis, MO (Washington University in St. Louis)
SEQUENCING CORE
- Houston, TX (Baylor College of Medicine)
For funding information, please visit the NIH Common Fund website.